|
CELLCAP TECHNOLOGIES LIMITED
REGISTERED NUMBER: 08015904
ABBREVIATED BALANCE SHEET
AS AT 30 APRIL 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CREDITORS: amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS LESS CURRENT LIABILITIES
|
|
|
|
The directors consider that the company is entitled to exemption from the requirement to have an audit under the provisions of section 477 of the Companies Act 2006 ("the Act") and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and for preparing financial statements which give a true and fair view of the state of affairs of the company as at 30 April 2015 and of its loss for the year in accordance with the requirements of sections 394 and 395 of the Act and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
The abbreviated accounts, which have been prepared in accordance with the provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006, were approved and authorised for issue by the board and were signed on its behalf on 18 January 2016.
The notes on pages 2 to 3 form part of these financial statements.
Page 1
|
|
CELLCAP TECHNOLOGIES LIMITED
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 30 APRIL 2015
1.ACCOUNTING POLICIES
|
|
|
Basis of preparation of financial statements
|
|
|
|
The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).
|
|
|
|
|
|
|
|
The company has cash resources and has no requirement for external funding. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. They continue to believe the going concern basis of accounting appropriate in preparing the annual financial statements.
|
|
|
|
|
|
|
|
Turnover comprises revenue recognised by the company in respect of goods and services supplied during the year, exclusive of Value Added Tax and trade discounts.
|
|
|
|
Intangible fixed assets and amortisation
|
|
|
|
Patents are stated at cost less amortisation. Amortisation is provided at rates calculated to write off the cost of patents, less their estimated residual value, over their expected useful lives on the following bases:
|
|
|
|
|
|
|
|
Amortisation is provided at the following rates:
 
|
2.INTANGIBLE FIXED ASSETS
Page 2
|
|
CELLCAP TECHNOLOGIES LIMITED
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 30 APRIL 2015
3.SHARE CAPITAL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allotted, called up and fully paid
|
|
|
|
|
|
|
|
|
|
|
|
101 Ordinary shares of £1 each
|
|
|
|
|
|
2 (2014 - 1) Preference shares of £1 each
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On 27 January 2015 the company issued 1 preference share of £1 at a premium of £49,999 per share; the consideration received was £50,000.
The financial statements for the period ended 30 April 2013 disclosed the preference share in issue as having a nominal value of £74,999; the financial statements for 2014 were amended to show the correct nominal value of the preference share as £1 with the balance of the consideration paid being share premium.
Page 3
|
